DiaMedica Inc. announced that Mark Robbins has resigned his position with the company to pursue other Opportunities. Mark joined DiaMedica as Vice President of Clinical and Regulatory and was named Executive Vice President in July 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.47 USD | +8.44% |
|
+19.66% | +22.18% |
Jul. 01 | DiaMedica Therapeutics Inc. announced that it has received $11.8 million in funding | CI |
Jun. 27 | Transcript : DiaMedica Therapeutics Inc. - Special Call |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.18% | 148M | |
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Announces Resignation of Mark Robbins as Executive Vice President